More scare tactics from Irv Weissman and co. from Stanford. Proposition 71 (which passed over a year ago) bonds have not been able to be sold to do embryo cloning because several lawsuits are pending. Two cancer researchers, who Stanford has been courting with the possible gravy train, prop. 71 bonds will provide, have declined the invitation and are moving on to Singapore where ethical concerns are lacking.

In the San Jose Mercury news, Lisa Krieger writes,“It is a loss for Stanford and a loss for
America,” Weissman said. “Without a doubt, they are the best people I know to find out which genes are altered to cause cancer.”

“When they do their work, it will be for Singapore,” he said. “They’ll conduct their clinical trials in Singapore. The first place their work will be patented and used will be Singapore.”

It is odd, when it is politically uncorrect to be pro-America, that Weissman begrudges Singapore to be first in line for cures and profits from patenting.

Author Profile

Jennifer Lahl, CBC Founder
Jennifer Lahl, CBC Founder
Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.